Corvus Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Assets
Corvus Pharmaceuticals, Inc. (CRVS) reported Increase (Decrease) in Other Operating Assets of $163.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-11-12
- Corvus Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2024-09-30 was $123.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2024-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $163.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $40.00K 10-Q · filed 2024-08-06 | ||
| 2023-09-30 | -$40.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |